BackgroundBladder cancer is the ninth most common type of cancer worldwide. In the past, radical cystectomy via open surgery has been considered the gold-standard treatment for muscle invasive bladder cancer. However, in recent years there has been a progressive increase in the use of robot-assisted laparoscopic radical cystectomy. The aim of the current project is to investigate the surgical, oncological, and functional outcomes of patients with bladder cancer who undergo radical cystectomy comparing three different surgical techniques (robotic-assisted, laparoscopic, and open surgery). Pre-, peri- and post-operative factors will be examined, and participants will be followed for a period of up to 24months to identify risks of mortality, oncological outcomes, hospital readmission, sexual performance, and continence.MethodsWe describe a protocol for an observational, prospective, multicenter, cohort study to assess patients affected by bladder neoplasms undergoing radical cystectomy and urinary diversion. The Italian Radical Cystectomy Registry is an electronic registry to prospectively collect the data of patients undergoing radical cystectomy conducted with any technique (open, laparoscopic, robotic-assisted). Twenty-eight urology departments across Italy will provide data for the study, with the recruitment phase between 1st January 2017-31st October 2020. Information is collected from the patients at the moment of surgical intervention and during follow-up (3, 6, 12, and 24months after radical cystectomy). Peri-operative variables include surgery time, type of urinary diversion, conversion to open surgery, bleeding, nerve sparing and lymphadenectomy. Follow-up data collection includes histological information (e.g., post-op staging, grading, and tumor histology), short- and long-term outcomes (e.g., mortality, post-op complications, hospital readmission, sexual potency, continence etc).DiscussionThe current protocol aims to contribute additional data to the field concerning the short- and long-term outcomes of three different radical cystectomy surgical techniques for patients with bladder cancer, including open, laparoscopic, and robot-assisted. This is a comparative-effectiveness trial that takes into account a complex range of factors and decision making by both physicians and patients that affect their choice of surgical technique.Trial registrationClinicalTrials.gov, NCT04228198. Registered 14th January 2020- Retrospectively registered.

Protocol of the Italian Radical Cystectomy Registry (RIC): a non-randomized, 24-month, multicenter study comparing robotic-assisted, laparoscopic, and open surgery for radical cystectomy in bladder cancer / Porreca, Angelo; Palmer, Katie; Artibani, Walter; Antonelli, Alessandro; Bianchi, Lorenzo; Brunocilla, Eugenio; Bocciardi, Aldo Massimo; Brausi, Maurizio; Busetto, Gian Maria; Carini, Marco; Carrieri, Giuseppe; Celia, Antonio; Cindolo, Luca; Cochetti, Giovanni; Colombo, Renzo; De Berardinis, Ettore; De Cobelli, Ottavio; Di Maida, Fabrizio; Ercolino, Amelio; Gaboardi, Franco; Galfano, Antonio; Gallina, Andrea; Gallucci, Michele; Introini, Carlo; Mearini, Ettore; Minervini, Andrea; Montorsi, Francesco; Musi, Gennaro; Pini, Giovannalberto; Schiavina, Riccardo; Secco, Silvia; Serni, Sergio; Simeone, Claudio; Tasso, Giovanni; D'Agostino, Daniele. - In: BMC CANCER. - ISSN 1471-2407. - ELETTRONICO. - 21:(2021), pp. 0-0. [10.1186/s12885-020-07748-7]

Protocol of the Italian Radical Cystectomy Registry (RIC): a non-randomized, 24-month, multicenter study comparing robotic-assisted, laparoscopic, and open surgery for radical cystectomy in bladder cancer

Carini, Marco;Di Maida, Fabrizio;Minervini, Andrea;Serni, Sergio;Tasso, Giovanni;
2021

Abstract

BackgroundBladder cancer is the ninth most common type of cancer worldwide. In the past, radical cystectomy via open surgery has been considered the gold-standard treatment for muscle invasive bladder cancer. However, in recent years there has been a progressive increase in the use of robot-assisted laparoscopic radical cystectomy. The aim of the current project is to investigate the surgical, oncological, and functional outcomes of patients with bladder cancer who undergo radical cystectomy comparing three different surgical techniques (robotic-assisted, laparoscopic, and open surgery). Pre-, peri- and post-operative factors will be examined, and participants will be followed for a period of up to 24months to identify risks of mortality, oncological outcomes, hospital readmission, sexual performance, and continence.MethodsWe describe a protocol for an observational, prospective, multicenter, cohort study to assess patients affected by bladder neoplasms undergoing radical cystectomy and urinary diversion. The Italian Radical Cystectomy Registry is an electronic registry to prospectively collect the data of patients undergoing radical cystectomy conducted with any technique (open, laparoscopic, robotic-assisted). Twenty-eight urology departments across Italy will provide data for the study, with the recruitment phase between 1st January 2017-31st October 2020. Information is collected from the patients at the moment of surgical intervention and during follow-up (3, 6, 12, and 24months after radical cystectomy). Peri-operative variables include surgery time, type of urinary diversion, conversion to open surgery, bleeding, nerve sparing and lymphadenectomy. Follow-up data collection includes histological information (e.g., post-op staging, grading, and tumor histology), short- and long-term outcomes (e.g., mortality, post-op complications, hospital readmission, sexual potency, continence etc).DiscussionThe current protocol aims to contribute additional data to the field concerning the short- and long-term outcomes of three different radical cystectomy surgical techniques for patients with bladder cancer, including open, laparoscopic, and robot-assisted. This is a comparative-effectiveness trial that takes into account a complex range of factors and decision making by both physicians and patients that affect their choice of surgical technique.Trial registrationClinicalTrials.gov, NCT04228198. Registered 14th January 2020- Retrospectively registered.
2021
21
0
0
Porreca, Angelo; Palmer, Katie; Artibani, Walter; Antonelli, Alessandro; Bianchi, Lorenzo; Brunocilla, Eugenio; Bocciardi, Aldo Massimo; Brausi, Maurizio; Busetto, Gian Maria; Carini, Marco; Carrieri, Giuseppe; Celia, Antonio; Cindolo, Luca; Cochetti, Giovanni; Colombo, Renzo; De Berardinis, Ettore; De Cobelli, Ottavio; Di Maida, Fabrizio; Ercolino, Amelio; Gaboardi, Franco; Galfano, Antonio; Gallina, Andrea; Gallucci, Michele; Introini, Carlo; Mearini, Ettore; Minervini, Andrea; Montorsi, Francesco; Musi, Gennaro; Pini, Giovannalberto; Schiavina, Riccardo; Secco, Silvia; Serni, Sergio; Simeone, Claudio; Tasso, Giovanni; D'Agostino, Daniele
File in questo prodotto:
File Dimensione Formato  
10.1186s12885-020-07748-7.pdf

Accesso chiuso

Tipologia: Pdf editoriale (Version of record)
Licenza: DRM non definito
Dimensione 1.06 MB
Formato Adobe PDF
1.06 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1287591
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 5
social impact